array:24 [
  "pii" => "S1578219011000448"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2011.04.001"
  "estado" => "S300"
  "fechaPublicacion" => "2011-09-01"
  "aid" => "393"
  "copyright" => "Elsevier España, S.L. and AEDV"
  "copyrightAnyo" => "2011"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2011;102:484-6"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3045
    "formatos" => array:3 [
      "EPUB" => 42
      "HTML" => 2196
      "PDF" => 807
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S000173101100192X"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2011.04.001"
      "estado" => "S300"
      "fechaPublicacion" => "2011-09-01"
      "aid" => "393"
      "copyright" => "Elsevier España, S.L. y AEDV"
      "documento" => "article"
      "crossmark" => 0
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2011;102:484-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 6415
        "formatos" => array:3 [
          "EPUB" => 1
          "HTML" => 4582
          "PDF" => 1832
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Art&#237;culo de opini&#243;n</span>"
        "titulo" => "Hemangiomas de la infancia&#58; pasado&#44; presente y futuro del tratamiento con propranolol"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "484"
            "paginaFinal" => "486"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Past&#44; Present&#44; and Future of Propranolol for Hemangiomas of Infancy"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "E&#46; Baselga"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "E&#46;"
                "apellidos" => "Baselga"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219011000448"
          "doi" => "10.1016/j.adengl.2011.04.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219011000448?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101100192X?idApp=UINPBA000044"
      "url" => "/00017310/0000010200000007/v1_201304241332/S000173101100192X/v1_201304241332/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219011000412"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2011.03.003"
    "estado" => "S300"
    "fechaPublicacion" => "2011-09-01"
    "aid" => "372"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and AEDV"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "ssu"
    "cita" => "Actas Dermosifiliogr. 2011;102:487-97"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 8107
      "formatos" => array:3 [
        "EPUB" => 42
        "HTML" => 6333
        "PDF" => 1732
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
      "titulo" => "Connective Tissue Diseases and Psoriasis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "487"
          "paginaFinal" => "497"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Conectivopat&#237;as y psoriasis"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1736
              "Ancho" => 2403
              "Tamanyo" => 196687
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Naive T helper &#40;T<span class="elsevierStyleInf">H</span>&#41; cells differentiate into 3 different subsets &#40;T<span class="elsevierStyleInf">H</span>1&#44;T<span class="elsevierStyleInf">H</span>2&#44;and T<span class="elsevierStyleInf">H</span>17&#41; depending on the cytokine stimuli they receive&#46; Transforming growth factor &#40;TGF&#41; &#946; and interleukin &#40;IL&#41; 6 are the primary mediators of differentiation into T<span class="elsevierStyleInf">H</span>17 cells&#44; while IL-23 contributes to the survival and proliferation of these cells&#46; Among the many cytokines secreted by T<span class="elsevierStyleInf">H</span>17 cells&#44; IL-21 intervenes in a positive feedback loop&#46; IFN indicates interferon&#59; TNF&#44; tumor necrosis factor&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Cuesta-Montero, I&#46; Belinch&#243;n"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Cuesta-Montero"
            ]
            1 => array:2 [
              "nombre" => "I&#46;"
              "apellidos" => "Belinch&#243;n"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731011001384"
        "doi" => "10.1016/j.ad.2011.03.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731011001384?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219011000412?idApp=UINPBA000044"
    "url" => "/15782190/0000010200000007/v1_201304241231/S1578219011000412/v1_201304241231/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S157821901100045X"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2011.03.006"
    "estado" => "S300"
    "fechaPublicacion" => "2011-09-01"
    "aid" => "377"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "edi"
    "cita" => "Actas Dermosifiliogr. 2011;102:481-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3126
      "formatos" => array:3 [
        "EPUB" => 42
        "HTML" => 2473
        "PDF" => 611
      ]
    ]
    "en" => array:9 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "<span class="elsevierStyleItalic">Actas Dermo-Sifiliogr&#225;ficas</span> Continues to Expand&#58; Presentation of New Sections"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "481"
          "paginaFinal" => "483"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "<span class="elsevierStyleItalic">Actas</span> sigue creciendo&#46; Presentaci&#243;n de las nuevas secciones de <span class="elsevierStyleItalic">Actas Dermo-Sifiliogr&#225;ficas</span>"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S000173101100161X"
        "doi" => "10.1016/j.ad.2011.03.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101100161X?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901100045X?idApp=UINPBA000044"
    "url" => "/15782190/0000010200000007/v1_201304241231/S157821901100045X/v1_201304241231/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Opinion Article</span>"
    "titulo" => "Past&#44; Present&#44; and Future of Propranolol for Hemangiomas of Infancy"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "484"
        "paginaFinal" => "486"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "E&#46; Baselga"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "E&#46;"
            "apellidos" => "Baselga"
            "email" => array:1 [
              0 => "dra&#46;baselga&#64;gmail&#46;com"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital de la Santa Creu i Sant Pau&#44; Barcelona&#44; Spain"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Hemangiomas de la infancia&#58; pasado&#44; presente y futuro del tratamiento con propranolol"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Hemangiomas of infancy are the most common vascular tumors of childhood&#44; affecting 10&#37; of newborns&#44; especially females&#46; Hemangiomas are biologically unique&#44; and unlike other proliferative lesions&#44; they tend to regress and resolve spontaneously through mechanisms involving intracellular events or signals that are still only partially understood&#46; In many cases&#44; a wait-and-see approach is therefore all that is required&#46; About 10&#37; of hemangiomas are treated&#44; however&#44; because they may compromise vital functions&#44; because ulceration develops&#44; or because they potentially leave the skin disfigured&#46; While it is true that these tumors resolve&#44; treatment can be justified by the fact that they will not necessarily disappear without a trace&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Furthermore&#44; full resolution can take years and the psychological impact the birthmark may have during the early years of a child&#39;s socialization is unpredictable&#46; In this issue of <span class="elsevierStyleItalic">Actas Dermo-Sifiliogr&#225;ficas</span>&#44; Bernabeu and coworkers<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> report on a relatively large series of infantile hemangiomas treated with propranolol&#44; one of the most recently introduced therapeutic alternatives&#46; In this article I review what is known about these vascular tumors&#44; reflect on past and present approaches to management&#44; and outline my view of what the future will bring&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Hemangiomas of Infancy&#58; The Past</span><p id="par0010" class="elsevierStylePara elsevierViewall">Perhaps as a result of their high frequency&#44; hemangiomas have generally been understood to be benign&#46; Nevertheless&#44; medicine has still searched persistently for a way to treat them&#46; New treatment modalities have been greeted with enthusiasm&#44; although some were then abandoned in spite of their efficacy because the side effects could not be justified for the treatment of what remains a benign lesion&#46; Others&#44; such as oral corticosteroids&#44; have prevailed over the years as we have waited for better or safer treatments to appear&#46; Some options&#44; such as surgical removal&#44; were taken up once again after periods of disuse&#44; as occurred when radiotherapy&#44; which was popular in the 1950s&#44; was later proscribed after follow-up brought to light complications such as radiodermatitis and skin cancer in the irradiated zone&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">When hemangiomas were reported to respond to systemic corticosteroids at the end of the 1960s&#44;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> this therapy became perhaps the first major advance in the medical management of these tumors and over time we gained a better understanding of the optimal dosage as well as the risks&#46; One of the main disadvantages of systemic corticosteroid treatment is that these drugs only act on the proliferative phase&#44; leaving a very small window of opportunity to initiate therapy with assurance of success given that hemangiomas reach 80&#37; of their size within the first 3 months&#46; Oral corticosteroids halt growth in nearly 80&#37; of patients&#44; but rapid reduction in volume occurs in only a third&#46; Moreover&#44; the use of these drugs to treat hemangiomas requires much higher dosages &#40;nearly 3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;d&#41; than those used for other indications&#46; High dosages can lead to delayed growth and suppression of the hypothalamic-pituitary-adrenal axis&#44; although the effect is reversed on suspension of treatment&#46; The greatest concern&#44; however&#44; is immunosuppression&#44; which can increase the risk of serious opportunistic infections&#44; such as <span class="elsevierStyleItalic">Pneumocystis jiroveci</span> pneumonia&#44; in children who are in fact being treated for a birthmark that is not life-threatening&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Another unresolved problem is interference with the child&#39;s vaccination schedule&#58; at present we do not know if it is appropriate to vaccinate patients under such treatment or if vaccination should be delayed until after treatment or repeated once treatment is complete&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In the 1990s&#44; a group led by Folkman&#44; who pioneered research on the mechanisms of angiogenesis&#44; described the efficacy of interferon in hemangiomas of infancy even in cases that were unresponsive to corticosteroids&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> However&#44; the description of spastic diplegia in up to 10&#37; of treated patients relegated this approach to use only in tumors that were resistant and life-threatening&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">In the search for safer antiangiogenic drugs for cases refractory to oral corticosteroids&#44; Enjorlas and coworkers<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> tested vincristine&#46; This drug&#44; while slow to act&#44; proved highly effective and had few adverse effects&#46; The only route of administration&#44; however&#44; is a central venous line&#44; which presents evident problems when treating an infant for a nonmalignant growth&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Hemangiomas of Infancy&#58; The Current Situation</span><p id="par0030" class="elsevierStylePara elsevierViewall">The discovery that propranolol was effective in this setting was a casual observation by alert French dermatologists&#44;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> whose report once again changed our therapeutic approach to these tumors radically&#46; Response to propranolol is so good and rapid that nearly 100 articles have been published on this use since the first study appeared in 2008&#46; This drug is not new&#58; it has been on the market since 1964&#44; and its pharmacokinetics and side effects are well known&#46; Propranolol has been shown to be effective on hemangiomas of all types and locations&#44; including lesions affecting the throat and liver and those that have become ulcerated&#46; Moreover&#44; this drug acts well beyond the proliferative phase&#44; even benefiting patients as old as 2&#46;5 years&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Response is so rapid that color changes can be seen within 24<span class="elsevierStyleHsp" style=""></span>hours&#46; Maximum response is usually evident at 10 weeks and a plateau occurs at around 20 weeks&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> The dosage in most studies has been 2<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;d&#44; divided into 2 or 3 doses&#46; Assessment by a cardiologist is recommended prior to treatment&#44; and blood pressure&#44; heart rate&#44; and blood sugar levels should be monitored&#44; especially after the first few doses and after any increase in dosage&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Hemangiomas of Infancy&#58; The Future</span><p id="par0035" class="elsevierStylePara elsevierViewall">Given the excellent results seen with propranolol&#44; it is my opinion that this drug will replace systemic corticosteroids as the first-line therapy for hemangiomas of infancy&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Many questions remain&#44; however&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> The dose-response curve has not yet been established&#44; for example&#46; Although most studies have prescribed 2<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;d&#44; many have used lower or higher dosages with good results&#46; That there is a dose-effect relationship is known&#44; as a better outcome has been observed at higher doses&#46; However&#44; we do not know if using higher doses will allow us to prescribe shorter regimens or if&#44; on the other hand&#44; lower doses taken over a longer period might give the same results with less risk&#46; The optimal duration of treatment has also not yet been established&#46; Although there is a notion that the hemangioma is likely to grow back if treatment is interrupted before the age of 6 to 9 months&#44; no clinical trials have yet compared treatment regimens with different durations&#46; In fact&#44; we have sometimes seen hemangiomas grow back after interrupting treatment at 18 months of age&#44; well past the tumor&#39;s proliferative phase&#46; We have also yet to see trials comparing propranolol to oral corticosteroids&#44; or trials assessing combination therapy&#46;The mechanism that might explain propranolol&#39;s effect on hemangiomas of infancy is also poorly understood at this time&#44; although it has been suggested that it may be related to control of hypoxia&#44; the induction of apoptosis&#44; the reduction of vascular endothelial growth factor or fibroblast growth factor&#44; or even attenuation of renin-angiotensin system activity in the endothelium of the hemangioma itself&#46;<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13&#8211;15</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">When large facial hemangiomas are treated with propranolol&#44; we still know little of the possible risks or the best way to monitor for the main adverse events &#40;principally hypotension&#44; bradycardia&#44; bronchospasm&#44; hypoglycemia&#44; and hyperkalemia&#41;&#46; For this reason&#44; individual hospitals have established their own protocols in keeping with available resources&#59; practices range from hospital admission for the first days of treatment to observation in a day hospital&#44; outpatient monitoring by health care staff&#44; or parent monitoring of blood pressure at home&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> The risk of treating large facial hemangiomas accompanied by agenesis&#44; hypoplasia&#44; and tortuosity of large cerebral vessels &#40;PHACE syndrome&#41; is another area where knowledge is lacking&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">It is very important to remember that propranolol has not been approved for use in treating infantile hemangioma&#46; Its prescription therefore necessarily falls into the category of compassionate use&#46; This should be of particular concern to us&#44; as these tumors are not usually life-threatening and as most patients are in the age range when the incidence of sudden infant death is highest&#46; Written informed consent must therefore be obtained before treatment can start&#46; Even when parents have consented&#44; however&#44; the prescribing physician&#39;s burden of responsibility is great&#44; particularly since it not usually difficult to obtain permission from parents who trust their doctor&#46; The answer to our questions about the use of this drug in hemangiomas of infancy&#44; and the approval of this indication&#44; will depend on the completion of randomized clinical trials&#46; Unfortunately&#44; trials of drugs that have been on the market for so long are always difficult and costly because the pharmaceutical industry usually lacks interest in funding them&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Analysis of the 36 hemangiomas in the series reported by Bernabeu and coworkers&#44;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> in spite of the limitations of its retrospective study design&#44; supports the view of this drug&#39;s prospects as I have explained them&#58; its clinical efficacy is more than promising and its safety profile is good&#44; as shown by the adoption of this therapeutic alternative by important centers in Spain and its inclusion in international guidelines&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Various randomized placebo-controlled trials are underway to compare different doses of the drug over different periods&#44; and there are also trials comparing propranolol to oral corticosteroids and other &#946;-blockers such as nadolol&#46; A list of such studies can be consulted at <a href="http://clinicaltrials.gov/">http&#58;&#47;&#47;clinicaltrials&#46;gov&#47;</a>&#46; At this time I would like to encourage pediatric and other dermatologists who treat infants with hemangiomas to explain this option to families&#46; If the infant&#39;s lesion might be treatable with propranolol&#44; the physician can propose enrollment in a worldwide multicenter study in which Spain is participating&#46; The inclusion criteria can be read at <a href="http://clinicaltrials.gov/ct2/show/study/NCT01056341">http&#58;&#47;&#47;clinicaltrials&#46;gov&#47;ct2&#47;show&#47;study&#47;NCT01056341</a>&#46; Participating hospitals include Hospital de la Santa Creu i Sant Pau in Barcelona and Hospital San Juan de Dios in Barcelona&#59; Hospital La Paz and Hospital del Ni&#241;o Jes&#250;s in Madrid&#59; Hospital Virgen del Roc&#237;o in Seville&#59; Hospital Universitario de La Coru&#241;a in La Coru&#241;a&#59; and Hospital Universitario de Valencia in Valencia&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">In conclusion&#44; hemangiomas of infancy constitute a fast-moving field in which treatment options are constantly being reconsidered&#44; as reflected in the changes that have taken place over the past 4 decades&#46; The recent addition of propranolol to the therapeutic arsenal for hemangioma has improved the clinical response we can expect&#46; As we learn more about this drug&#39;s mechanisms of action in this clinical setting&#44; we can also expect to extend our understanding of the pathogenesis of these benign endothelial tumors&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflict of Interest</span><p id="par0070" class="elsevierStylePara elsevierViewall">Dr Baselga is a principal investigator and coordinator of the HEMANGIOL study in Spain&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:5 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Hemangiomas of Infancy&#58; The Past"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Hemangiomas of Infancy&#58; The Current Situation"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Hemangiomas of Infancy&#58; The Future"
        ]
        3 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Conflict of Interest"
        ]
        4 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara">Please cite this article as&#58; Baselga A&#44; Hemangiomas de la infancia&#58; pasado&#44; presente y future del tratamiento con propranolol&#46; Actas Dermosifiliogr&#46;2011&#59;102&#58;484-86&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:16 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective Study of Infantile Hemangiomas&#58; Clinical Characteristics Predicting Complications and Treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;N&#46; Haggstrom"
                            1 => "B&#46;A&#46; Drolet"
                            2 => "E&#46; Baselga"
                            3 => "S&#46;L&#46; Chamlin"
                            4 => "M&#46;C&#46; Garzon"
                            5 => "K&#46;A&#46; Horii"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1542/peds.2006-0413"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatrics"
                        "fecha" => "2006"
                        "volumen" => "118"
                        "paginaInicial" => "882"
                        "paginaFinal" => "887"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16950977"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tratamiento con propanolol oral para hemangiomas infantiles graves&#58; series de 28 pacientes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46; Bernabeu- Wittel"
                            1 => "J&#46;J&#46; Pereyra-Rodr&#237;guez"
                            2 => "M&#46;E&#46; Mantrana-Bermejo"
                            3 => "I&#46; Fern&#225;ndez-Pineda"
                            4 => "J&#46;C&#46; de Agustin"
                            5 => "J&#46; Conejo-Mir"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ad.2011.02.009"
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2011"
                        "volumen" => "102"
                        "paginaInicial" => "510"
                        "paginaFinal" => "516"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21514550"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of hemangioma of the skin in infancy and childhood by roentgen irradiation and radium"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Abdulkerin"
                            1 => "J&#46;A&#46; Boyd"
                            2 => "R&#46;J&#46; Reeves"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatrics"
                        "fecha" => "1954"
                        "volumen" => "14"
                        "paginaInicial" => "523"
                        "paginaFinal" => "527"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/13214967"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Induced resolution of cavernous hemangiomas following prednisolone therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "H&#46;A&#46; Zarem"
                            1 => "M&#46;T&#46; Edgerton"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Plast Reconstr Surg"
                        "fecha" => "1967"
                        "volumen" => "39"
                        "paginaInicial" => "76"
                        "paginaFinal" => "83"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6018814"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pneumocystis carinii Pneumonia in Infant Treated With Oral Steroids for Hemangioma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "M&#46;L&#46; Maronn"
                            1 => "T&#46; Corden"
                            2 => "B&#46;A&#46; Drolet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archderm.143.9.1224"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "2007"
                        "volumen" => "143"
                        "paginaInicial" => "1224"
                        "paginaFinal" => "1225"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17875903"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46;E&#46; Kelly"
                            1 => "A&#46;M&#46; Juern"
                            2 => "W&#46;J&#46; Grossman"
                            3 => "D&#46;W&#46; Schauer"
                            4 => "B&#46;A&#46; Drolet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archdermatol.2010.90"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "2010"
                        "volumen" => "146"
                        "paginaInicial" => "767"
                        "paginaFinal" => "774"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20479291"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interferon alfa-2a therapy for life-threatening hemangiomas of infancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;A&#46; Ezekowitz"
                            1 => "J&#46;B&#46; Mulliken"
                            2 => "J&#46; Folkman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM199205283262203"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "1992"
                        "volumen" => "326"
                        "paginaInicial" => "1456"
                        "paginaFinal" => "1463"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1489383"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;F&#46; Barlow"
                            1 => "C&#46;J&#46; Priebe"
                            2 => "J&#46;B&#46; Mulliken"
                            3 => "P&#46;D&#46; Barnes"
                            4 => "D&#46; Mac Donald"
                            5 => "J&#46; Folkman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "1998"
                        "volumen" => "132"
                        "paginaInicial" => "527"
                        "paginaFinal" => "530"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9544915"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#91;Vincritine treatment for function- and life-threatening infantile hemangioma&#93; Traitement par vincristine des hemangiomes graves du nourrisson"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "O&#46; Enjolras"
                            1 => "G&#46;M&#46; Breviere"
                            2 => "G&#46; Roger"
                            3 => "M&#46; Tovi"
                            4 => "B&#46; Pellegrino"
                            5 => "E&#46; Varotti"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.arcped.2003.10.014"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Pediatr"
                        "fecha" => "2004"
                        "volumen" => "11"
                        "paginaInicial" => "99"
                        "paginaFinal" => "107"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14761730"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Propranolol for severe hemangiomas of infancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "C&#46; Leaute-Labreze"
                            1 => "R&#46;E&#46; Dumas de la"
                            2 => "T&#46; Hubiche"
                            3 => "F&#46; Boralevi"
                            4 => "J&#46;B&#46; Thambo"
                            5 => "A&#46; Taieb"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMc0708819"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2008"
                        "volumen" => "358"
                        "paginaInicial" => "2649"
                        "paginaFinal" => "2651"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18550886"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful treatment of infantile haemangiomas of the orbit with propranolol"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Y&#46;C&#46; Li"
                            1 => "E&#46; McCahon"
                            2 => "N&#46;A&#46; Rowe"
                            3 => "P&#46;A&#46; Martin"
                            4 => "G&#46;A&#46; Wilcsek"
                            5 => "F&#46;J&#46; Martin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1442-9071.2010.02327.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Experiment Ophthalmol"
                        "fecha" => "2010"
                        "volumen" => "38"
                        "paginaInicial" => "554"
                        "paginaFinal" => "559"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20491798"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Propranolol for Infantile Hemangiomas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Bagazgoitia"
                            1 => "A&#46; Torrelo"
                            2 => "J&#46;C&#46; Guti&#233;rrez"
                            3 => "A&#46; Hern&#225;ndez-Mart&#237;n"
                            4 => "P&#46; Luna"
                            5 => "M&#46; Guti&#233;rrez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1525-1470.2011.01345.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Dermatol"
                        "fecha" => "2011"
                        "volumen" => "28"
                        "paginaInicial" => "108"
                        "paginaFinal" => "114"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21385205"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Propranolol for infantile hemangiomas&#58; promise&#44; peril&#44; pathogenesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "I&#46;J&#46; Frieden"
                            1 => "B&#46;A&#46; Drolet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1525-1470.2009.00977.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Dermatol"
                        "fecha" => "2009"
                        "volumen" => "26"
                        "paginaInicial" => "642"
                        "paginaFinal" => "644"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19840341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Itinteang T&#44; Brasch HD&#44; Tan ST&#44; Day DJ&#46; Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution&#46; J Plast Reconstr Aesthet Surg&#46; 2011&#59;64&#58;759&#8211;65&#46; Epub 2010 Sep 26&#46;"
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Propranolol for infantile haemangiomas&#58; insights into the molecular mechanisms of action"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46;H&#46; Storch"
                            1 => "P&#46;H&#46; Hoeger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2133.2010.09848.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2010"
                        "volumen" => "163"
                        "paginaInicial" => "269"
                        "paginaFinal" => "274"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20456345"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hypoglycemia as a Result of Propranolol During Treatment of Infantile Hemangioma&#58; A Case Report"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;M&#46; Breur"
                            1 => "M&#46; de Graaf"
                            2 => "C&#46;C&#46; Breugem"
                            3 => "S&#46;G&#46; Pasmans"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1525-1470.2010.01224.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Dermatol"
                        "fecha" => "2011"
                        "volumen" => "28"
                        "paginaInicial" => "169"
                        "paginaFinal" => "171"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20738795"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010200000007/v1_201304241231/S1578219011000448/v1_201304241231/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6152"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Opinion Article"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010200000007/v1_201304241231/S1578219011000448/v1_201304241231/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219011000448?idApp=UINPBA000044"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Opinion Article
Past, Present, and Future of Propranolol for Hemangiomas of Infancy
Hemangiomas de la infancia: pasado, presente y futuro del tratamiento con propranolol
E. Baselga
Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Leído
7598
Veces
se ha leído el artículo
2694
Total PDF
4904
Total HTML
Compartir estadísticas
 array:24 [
  "pii" => "S1578219011000448"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2011.04.001"
  "estado" => "S300"
  "fechaPublicacion" => "2011-09-01"
  "aid" => "393"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and AEDV"
  "copyrightAnyo" => "2011"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2011;102:484-6"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3045
    "formatos" => array:3 [
      "EPUB" => 42
      "HTML" => 2196
      "PDF" => 807
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S000173101100192X"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2011.04.001"
      "estado" => "S300"
      "fechaPublicacion" => "2011-09-01"
      "aid" => "393"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; y AEDV"
      "documento" => "article"
      "crossmark" => 0
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2011;102:484-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 6415
        "formatos" => array:3 [
          "EPUB" => 1
          "HTML" => 4582
          "PDF" => 1832
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Art&#237;culo de opini&#243;n</span>"
        "titulo" => "Hemangiomas de la infancia&#58; pasado&#44; presente y futuro del tratamiento con propranolol"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "484"
            "paginaFinal" => "486"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Past&#44; Present&#44; and Future of Propranolol for Hemangiomas of Infancy"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "E&#46; Baselga"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "E&#46;"
                "apellidos" => "Baselga"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219011000448"
          "doi" => "10.1016/j.adengl.2011.04.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219011000448?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101100192X?idApp=UINPBA000044"
      "url" => "/00017310/0000010200000007/v1_201304241332/S000173101100192X/v1_201304241332/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219011000412"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2011.03.003"
    "estado" => "S300"
    "fechaPublicacion" => "2011-09-01"
    "aid" => "372"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and AEDV"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "ssu"
    "cita" => "Actas Dermosifiliogr. 2011;102:487-97"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 8107
      "formatos" => array:3 [
        "EPUB" => 42
        "HTML" => 6333
        "PDF" => 1732
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
      "titulo" => "Connective Tissue Diseases and Psoriasis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "487"
          "paginaFinal" => "497"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Conectivopat&#237;as y psoriasis"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1736
              "Ancho" => 2403
              "Tamanyo" => 196687
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Naive T helper &#40;T<span class="elsevierStyleInf">H</span>&#41; cells differentiate into 3 different subsets &#40;T<span class="elsevierStyleInf">H</span>1&#44;T<span class="elsevierStyleInf">H</span>2&#44;and T<span class="elsevierStyleInf">H</span>17&#41; depending on the cytokine stimuli they receive&#46; Transforming growth factor &#40;TGF&#41; &#946; and interleukin &#40;IL&#41; 6 are the primary mediators of differentiation into T<span class="elsevierStyleInf">H</span>17 cells&#44; while IL-23 contributes to the survival and proliferation of these cells&#46; Among the many cytokines secreted by T<span class="elsevierStyleInf">H</span>17 cells&#44; IL-21 intervenes in a positive feedback loop&#46; IFN indicates interferon&#59; TNF&#44; tumor necrosis factor&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Cuesta-Montero, I&#46; Belinch&#243;n"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Cuesta-Montero"
            ]
            1 => array:2 [
              "nombre" => "I&#46;"
              "apellidos" => "Belinch&#243;n"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731011001384"
        "doi" => "10.1016/j.ad.2011.03.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731011001384?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219011000412?idApp=UINPBA000044"
    "url" => "/15782190/0000010200000007/v1_201304241231/S1578219011000412/v1_201304241231/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S157821901100045X"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2011.03.006"
    "estado" => "S300"
    "fechaPublicacion" => "2011-09-01"
    "aid" => "377"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "edi"
    "cita" => "Actas Dermosifiliogr. 2011;102:481-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3126
      "formatos" => array:3 [
        "EPUB" => 42
        "HTML" => 2473
        "PDF" => 611
      ]
    ]
    "en" => array:9 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "<span class="elsevierStyleItalic">Actas Dermo-Sifiliogr&#225;ficas</span> Continues to Expand&#58; Presentation of New Sections"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "481"
          "paginaFinal" => "483"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "<span class="elsevierStyleItalic">Actas</span> sigue creciendo&#46; Presentaci&#243;n de las nuevas secciones de <span class="elsevierStyleItalic">Actas Dermo-Sifiliogr&#225;ficas</span>"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S000173101100161X"
        "doi" => "10.1016/j.ad.2011.03.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101100161X?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901100045X?idApp=UINPBA000044"
    "url" => "/15782190/0000010200000007/v1_201304241231/S157821901100045X/v1_201304241231/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Opinion Article</span>"
    "titulo" => "Past&#44; Present&#44; and Future of Propranolol for Hemangiomas of Infancy"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "484"
        "paginaFinal" => "486"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "E&#46; Baselga"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "E&#46;"
            "apellidos" => "Baselga"
            "email" => array:1 [
              0 => "dra&#46;baselga&#64;gmail&#46;com"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital de la Santa Creu i Sant Pau&#44; Barcelona&#44; Spain"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Hemangiomas de la infancia&#58; pasado&#44; presente y futuro del tratamiento con propranolol"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Hemangiomas of infancy are the most common vascular tumors of childhood&#44; affecting 10&#37; of newborns&#44; especially females&#46; Hemangiomas are biologically unique&#44; and unlike other proliferative lesions&#44; they tend to regress and resolve spontaneously through mechanisms involving intracellular events or signals that are still only partially understood&#46; In many cases&#44; a wait-and-see approach is therefore all that is required&#46; About 10&#37; of hemangiomas are treated&#44; however&#44; because they may compromise vital functions&#44; because ulceration develops&#44; or because they potentially leave the skin disfigured&#46; While it is true that these tumors resolve&#44; treatment can be justified by the fact that they will not necessarily disappear without a trace&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Furthermore&#44; full resolution can take years and the psychological impact the birthmark may have during the early years of a child&#39;s socialization is unpredictable&#46; In this issue of <span class="elsevierStyleItalic">Actas Dermo-Sifiliogr&#225;ficas</span>&#44; Bernabeu and coworkers<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> report on a relatively large series of infantile hemangiomas treated with propranolol&#44; one of the most recently introduced therapeutic alternatives&#46; In this article I review what is known about these vascular tumors&#44; reflect on past and present approaches to management&#44; and outline my view of what the future will bring&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Hemangiomas of Infancy&#58; The Past</span><p id="par0010" class="elsevierStylePara elsevierViewall">Perhaps as a result of their high frequency&#44; hemangiomas have generally been understood to be benign&#46; Nevertheless&#44; medicine has still searched persistently for a way to treat them&#46; New treatment modalities have been greeted with enthusiasm&#44; although some were then abandoned in spite of their efficacy because the side effects could not be justified for the treatment of what remains a benign lesion&#46; Others&#44; such as oral corticosteroids&#44; have prevailed over the years as we have waited for better or safer treatments to appear&#46; Some options&#44; such as surgical removal&#44; were taken up once again after periods of disuse&#44; as occurred when radiotherapy&#44; which was popular in the 1950s&#44; was later proscribed after follow-up brought to light complications such as radiodermatitis and skin cancer in the irradiated zone&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">When hemangiomas were reported to respond to systemic corticosteroids at the end of the 1960s&#44;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> this therapy became perhaps the first major advance in the medical management of these tumors and over time we gained a better understanding of the optimal dosage as well as the risks&#46; One of the main disadvantages of systemic corticosteroid treatment is that these drugs only act on the proliferative phase&#44; leaving a very small window of opportunity to initiate therapy with assurance of success given that hemangiomas reach 80&#37; of their size within the first 3 months&#46; Oral corticosteroids halt growth in nearly 80&#37; of patients&#44; but rapid reduction in volume occurs in only a third&#46; Moreover&#44; the use of these drugs to treat hemangiomas requires much higher dosages &#40;nearly 3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;d&#41; than those used for other indications&#46; High dosages can lead to delayed growth and suppression of the hypothalamic-pituitary-adrenal axis&#44; although the effect is reversed on suspension of treatment&#46; The greatest concern&#44; however&#44; is immunosuppression&#44; which can increase the risk of serious opportunistic infections&#44; such as <span class="elsevierStyleItalic">Pneumocystis jiroveci</span> pneumonia&#44; in children who are in fact being treated for a birthmark that is not life-threatening&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Another unresolved problem is interference with the child&#39;s vaccination schedule&#58; at present we do not know if it is appropriate to vaccinate patients under such treatment or if vaccination should be delayed until after treatment or repeated once treatment is complete&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In the 1990s&#44; a group led by Folkman&#44; who pioneered research on the mechanisms of angiogenesis&#44; described the efficacy of interferon in hemangiomas of infancy even in cases that were unresponsive to corticosteroids&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> However&#44; the description of spastic diplegia in up to 10&#37; of treated patients relegated this approach to use only in tumors that were resistant and life-threatening&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">In the search for safer antiangiogenic drugs for cases refractory to oral corticosteroids&#44; Enjorlas and coworkers<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> tested vincristine&#46; This drug&#44; while slow to act&#44; proved highly effective and had few adverse effects&#46; The only route of administration&#44; however&#44; is a central venous line&#44; which presents evident problems when treating an infant for a nonmalignant growth&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Hemangiomas of Infancy&#58; The Current Situation</span><p id="par0030" class="elsevierStylePara elsevierViewall">The discovery that propranolol was effective in this setting was a casual observation by alert French dermatologists&#44;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> whose report once again changed our therapeutic approach to these tumors radically&#46; Response to propranolol is so good and rapid that nearly 100 articles have been published on this use since the first study appeared in 2008&#46; This drug is not new&#58; it has been on the market since 1964&#44; and its pharmacokinetics and side effects are well known&#46; Propranolol has been shown to be effective on hemangiomas of all types and locations&#44; including lesions affecting the throat and liver and those that have become ulcerated&#46; Moreover&#44; this drug acts well beyond the proliferative phase&#44; even benefiting patients as old as 2&#46;5 years&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Response is so rapid that color changes can be seen within 24<span class="elsevierStyleHsp" style=""></span>hours&#46; Maximum response is usually evident at 10 weeks and a plateau occurs at around 20 weeks&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> The dosage in most studies has been 2<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;d&#44; divided into 2 or 3 doses&#46; Assessment by a cardiologist is recommended prior to treatment&#44; and blood pressure&#44; heart rate&#44; and blood sugar levels should be monitored&#44; especially after the first few doses and after any increase in dosage&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Hemangiomas of Infancy&#58; The Future</span><p id="par0035" class="elsevierStylePara elsevierViewall">Given the excellent results seen with propranolol&#44; it is my opinion that this drug will replace systemic corticosteroids as the first-line therapy for hemangiomas of infancy&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Many questions remain&#44; however&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> The dose-response curve has not yet been established&#44; for example&#46; Although most studies have prescribed 2<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;d&#44; many have used lower or higher dosages with good results&#46; That there is a dose-effect relationship is known&#44; as a better outcome has been observed at higher doses&#46; However&#44; we do not know if using higher doses will allow us to prescribe shorter regimens or if&#44; on the other hand&#44; lower doses taken over a longer period might give the same results with less risk&#46; The optimal duration of treatment has also not yet been established&#46; Although there is a notion that the hemangioma is likely to grow back if treatment is interrupted before the age of 6 to 9 months&#44; no clinical trials have yet compared treatment regimens with different durations&#46; In fact&#44; we have sometimes seen hemangiomas grow back after interrupting treatment at 18 months of age&#44; well past the tumor&#39;s proliferative phase&#46; We have also yet to see trials comparing propranolol to oral corticosteroids&#44; or trials assessing combination therapy&#46;The mechanism that might explain propranolol&#39;s effect on hemangiomas of infancy is also poorly understood at this time&#44; although it has been suggested that it may be related to control of hypoxia&#44; the induction of apoptosis&#44; the reduction of vascular endothelial growth factor or fibroblast growth factor&#44; or even attenuation of renin-angiotensin system activity in the endothelium of the hemangioma itself&#46;<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13&#8211;15</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">When large facial hemangiomas are treated with propranolol&#44; we still know little of the possible risks or the best way to monitor for the main adverse events &#40;principally hypotension&#44; bradycardia&#44; bronchospasm&#44; hypoglycemia&#44; and hyperkalemia&#41;&#46; For this reason&#44; individual hospitals have established their own protocols in keeping with available resources&#59; practices range from hospital admission for the first days of treatment to observation in a day hospital&#44; outpatient monitoring by health care staff&#44; or parent monitoring of blood pressure at home&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> The risk of treating large facial hemangiomas accompanied by agenesis&#44; hypoplasia&#44; and tortuosity of large cerebral vessels &#40;PHACE syndrome&#41; is another area where knowledge is lacking&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">It is very important to remember that propranolol has not been approved for use in treating infantile hemangioma&#46; Its prescription therefore necessarily falls into the category of compassionate use&#46; This should be of particular concern to us&#44; as these tumors are not usually life-threatening and as most patients are in the age range when the incidence of sudden infant death is highest&#46; Written informed consent must therefore be obtained before treatment can start&#46; Even when parents have consented&#44; however&#44; the prescribing physician&#39;s burden of responsibility is great&#44; particularly since it not usually difficult to obtain permission from parents who trust their doctor&#46; The answer to our questions about the use of this drug in hemangiomas of infancy&#44; and the approval of this indication&#44; will depend on the completion of randomized clinical trials&#46; Unfortunately&#44; trials of drugs that have been on the market for so long are always difficult and costly because the pharmaceutical industry usually lacks interest in funding them&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Analysis of the 36 hemangiomas in the series reported by Bernabeu and coworkers&#44;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> in spite of the limitations of its retrospective study design&#44; supports the view of this drug&#39;s prospects as I have explained them&#58; its clinical efficacy is more than promising and its safety profile is good&#44; as shown by the adoption of this therapeutic alternative by important centers in Spain and its inclusion in international guidelines&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Various randomized placebo-controlled trials are underway to compare different doses of the drug over different periods&#44; and there are also trials comparing propranolol to oral corticosteroids and other &#946;-blockers such as nadolol&#46; A list of such studies can be consulted at <a href="http://clinicaltrials.gov/">http&#58;&#47;&#47;clinicaltrials&#46;gov&#47;</a>&#46; At this time I would like to encourage pediatric and other dermatologists who treat infants with hemangiomas to explain this option to families&#46; If the infant&#39;s lesion might be treatable with propranolol&#44; the physician can propose enrollment in a worldwide multicenter study in which Spain is participating&#46; The inclusion criteria can be read at <a href="http://clinicaltrials.gov/ct2/show/study/NCT01056341">http&#58;&#47;&#47;clinicaltrials&#46;gov&#47;ct2&#47;show&#47;study&#47;NCT01056341</a>&#46; Participating hospitals include Hospital de la Santa Creu i Sant Pau in Barcelona and Hospital San Juan de Dios in Barcelona&#59; Hospital La Paz and Hospital del Ni&#241;o Jes&#250;s in Madrid&#59; Hospital Virgen del Roc&#237;o in Seville&#59; Hospital Universitario de La Coru&#241;a in La Coru&#241;a&#59; and Hospital Universitario de Valencia in Valencia&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">In conclusion&#44; hemangiomas of infancy constitute a fast-moving field in which treatment options are constantly being reconsidered&#44; as reflected in the changes that have taken place over the past 4 decades&#46; The recent addition of propranolol to the therapeutic arsenal for hemangioma has improved the clinical response we can expect&#46; As we learn more about this drug&#39;s mechanisms of action in this clinical setting&#44; we can also expect to extend our understanding of the pathogenesis of these benign endothelial tumors&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflict of Interest</span><p id="par0070" class="elsevierStylePara elsevierViewall">Dr Baselga is a principal investigator and coordinator of the HEMANGIOL study in Spain&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:5 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Hemangiomas of Infancy&#58; The Past"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Hemangiomas of Infancy&#58; The Current Situation"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Hemangiomas of Infancy&#58; The Future"
        ]
        3 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Conflict of Interest"
        ]
        4 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara">Please cite this article as&#58; Baselga A&#44; Hemangiomas de la infancia&#58; pasado&#44; presente y future del tratamiento con propranolol&#46; Actas Dermosifiliogr&#46;2011&#59;102&#58;484-86&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:16 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective Study of Infantile Hemangiomas&#58; Clinical Characteristics Predicting Complications and Treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;N&#46; Haggstrom"
                            1 => "B&#46;A&#46; Drolet"
                            2 => "E&#46; Baselga"
                            3 => "S&#46;L&#46; Chamlin"
                            4 => "M&#46;C&#46; Garzon"
                            5 => "K&#46;A&#46; Horii"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1542/peds.2006-0413"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatrics"
                        "fecha" => "2006"
                        "volumen" => "118"
                        "paginaInicial" => "882"
                        "paginaFinal" => "887"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16950977"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tratamiento con propanolol oral para hemangiomas infantiles graves&#58; series de 28 pacientes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46; Bernabeu- Wittel"
                            1 => "J&#46;J&#46; Pereyra-Rodr&#237;guez"
                            2 => "M&#46;E&#46; Mantrana-Bermejo"
                            3 => "I&#46; Fern&#225;ndez-Pineda"
                            4 => "J&#46;C&#46; de Agustin"
                            5 => "J&#46; Conejo-Mir"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ad.2011.02.009"
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2011"
                        "volumen" => "102"
                        "paginaInicial" => "510"
                        "paginaFinal" => "516"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21514550"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of hemangioma of the skin in infancy and childhood by roentgen irradiation and radium"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Abdulkerin"
                            1 => "J&#46;A&#46; Boyd"
                            2 => "R&#46;J&#46; Reeves"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatrics"
                        "fecha" => "1954"
                        "volumen" => "14"
                        "paginaInicial" => "523"
                        "paginaFinal" => "527"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/13214967"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Induced resolution of cavernous hemangiomas following prednisolone therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "H&#46;A&#46; Zarem"
                            1 => "M&#46;T&#46; Edgerton"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Plast Reconstr Surg"
                        "fecha" => "1967"
                        "volumen" => "39"
                        "paginaInicial" => "76"
                        "paginaFinal" => "83"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6018814"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pneumocystis carinii Pneumonia in Infant Treated With Oral Steroids for Hemangioma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "M&#46;L&#46; Maronn"
                            1 => "T&#46; Corden"
                            2 => "B&#46;A&#46; Drolet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archderm.143.9.1224"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "2007"
                        "volumen" => "143"
                        "paginaInicial" => "1224"
                        "paginaFinal" => "1225"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17875903"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46;E&#46; Kelly"
                            1 => "A&#46;M&#46; Juern"
                            2 => "W&#46;J&#46; Grossman"
                            3 => "D&#46;W&#46; Schauer"
                            4 => "B&#46;A&#46; Drolet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archdermatol.2010.90"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "2010"
                        "volumen" => "146"
                        "paginaInicial" => "767"
                        "paginaFinal" => "774"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20479291"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interferon alfa-2a therapy for life-threatening hemangiomas of infancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;A&#46; Ezekowitz"
                            1 => "J&#46;B&#46; Mulliken"
                            2 => "J&#46; Folkman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM199205283262203"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "1992"
                        "volumen" => "326"
                        "paginaInicial" => "1456"
                        "paginaFinal" => "1463"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1489383"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;F&#46; Barlow"
                            1 => "C&#46;J&#46; Priebe"
                            2 => "J&#46;B&#46; Mulliken"
                            3 => "P&#46;D&#46; Barnes"
                            4 => "D&#46; Mac Donald"
                            5 => "J&#46; Folkman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "1998"
                        "volumen" => "132"
                        "paginaInicial" => "527"
                        "paginaFinal" => "530"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9544915"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#91;Vincritine treatment for function- and life-threatening infantile hemangioma&#93; Traitement par vincristine des hemangiomes graves du nourrisson"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "O&#46; Enjolras"
                            1 => "G&#46;M&#46; Breviere"
                            2 => "G&#46; Roger"
                            3 => "M&#46; Tovi"
                            4 => "B&#46; Pellegrino"
                            5 => "E&#46; Varotti"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.arcped.2003.10.014"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Pediatr"
                        "fecha" => "2004"
                        "volumen" => "11"
                        "paginaInicial" => "99"
                        "paginaFinal" => "107"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14761730"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Propranolol for severe hemangiomas of infancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "C&#46; Leaute-Labreze"
                            1 => "R&#46;E&#46; Dumas de la"
                            2 => "T&#46; Hubiche"
                            3 => "F&#46; Boralevi"
                            4 => "J&#46;B&#46; Thambo"
                            5 => "A&#46; Taieb"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMc0708819"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2008"
                        "volumen" => "358"
                        "paginaInicial" => "2649"
                        "paginaFinal" => "2651"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18550886"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful treatment of infantile haemangiomas of the orbit with propranolol"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Y&#46;C&#46; Li"
                            1 => "E&#46; McCahon"
                            2 => "N&#46;A&#46; Rowe"
                            3 => "P&#46;A&#46; Martin"
                            4 => "G&#46;A&#46; Wilcsek"
                            5 => "F&#46;J&#46; Martin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1442-9071.2010.02327.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Experiment Ophthalmol"
                        "fecha" => "2010"
                        "volumen" => "38"
                        "paginaInicial" => "554"
                        "paginaFinal" => "559"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20491798"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Propranolol for Infantile Hemangiomas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Bagazgoitia"
                            1 => "A&#46; Torrelo"
                            2 => "J&#46;C&#46; Guti&#233;rrez"
                            3 => "A&#46; Hern&#225;ndez-Mart&#237;n"
                            4 => "P&#46; Luna"
                            5 => "M&#46; Guti&#233;rrez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1525-1470.2011.01345.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Dermatol"
                        "fecha" => "2011"
                        "volumen" => "28"
                        "paginaInicial" => "108"
                        "paginaFinal" => "114"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21385205"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Propranolol for infantile hemangiomas&#58; promise&#44; peril&#44; pathogenesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "I&#46;J&#46; Frieden"
                            1 => "B&#46;A&#46; Drolet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1525-1470.2009.00977.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Dermatol"
                        "fecha" => "2009"
                        "volumen" => "26"
                        "paginaInicial" => "642"
                        "paginaFinal" => "644"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19840341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Itinteang T&#44; Brasch HD&#44; Tan ST&#44; Day DJ&#46; Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution&#46; J Plast Reconstr Aesthet Surg&#46; 2011&#59;64&#58;759&#8211;65&#46; Epub 2010 Sep 26&#46;"
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Propranolol for infantile haemangiomas&#58; insights into the molecular mechanisms of action"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46;H&#46; Storch"
                            1 => "P&#46;H&#46; Hoeger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2133.2010.09848.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2010"
                        "volumen" => "163"
                        "paginaInicial" => "269"
                        "paginaFinal" => "274"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20456345"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hypoglycemia as a Result of Propranolol During Treatment of Infantile Hemangioma&#58; A Case Report"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;M&#46; Breur"
                            1 => "M&#46; de Graaf"
                            2 => "C&#46;C&#46; Breugem"
                            3 => "S&#46;G&#46; Pasmans"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1525-1470.2010.01224.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Dermatol"
                        "fecha" => "2011"
                        "volumen" => "28"
                        "paginaInicial" => "169"
                        "paginaFinal" => "171"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20738795"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010200000007/v1_201304241231/S1578219011000448/v1_201304241231/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6152"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Opinion Article"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010200000007/v1_201304241231/S1578219011000448/v1_201304241231/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219011000448?idApp=UINPBA000044"
]
Información del artículo
ISSN: 15782190
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 5 11 16
2024 Octubre 89 46 135
2024 Septiembre 98 31 129
2024 Agosto 130 45 175
2024 Julio 73 42 115
2024 Junio 90 37 127
2024 Mayo 88 31 119
2024 Abril 74 29 103
2024 Marzo 82 27 109
2024 Febrero 61 32 93
2024 Enero 57 38 95
2023 Diciembre 57 20 77
2023 Noviembre 60 23 83
2023 Octubre 67 33 100
2023 Septiembre 50 28 78
2023 Agosto 61 15 76
2023 Julio 65 38 103
2023 Junio 61 24 85
2023 Mayo 50 29 79
2023 Abril 40 34 74
2023 Marzo 49 15 64
2023 Febrero 70 29 99
2023 Enero 40 47 87
2022 Diciembre 73 65 138
2022 Noviembre 32 34 66
2022 Octubre 36 20 56
2022 Septiembre 39 47 86
2022 Agosto 38 44 82
2022 Julio 33 46 79
2022 Junio 42 35 77
2022 Mayo 88 41 129
2022 Abril 42 39 81
2022 Marzo 59 59 118
2022 Febrero 35 24 59
2022 Enero 34 42 76
2021 Diciembre 40 51 91
2021 Noviembre 22 43 65
2021 Octubre 34 55 89
2021 Septiembre 29 58 87
2021 Agosto 27 52 79
2021 Julio 32 38 70
2021 Junio 18 40 58
2021 Mayo 31 47 78
2021 Abril 47 58 105
2021 Marzo 39 20 59
2021 Febrero 38 26 64
2021 Enero 38 27 65
2020 Diciembre 19 11 30
2020 Noviembre 20 20 40
2020 Octubre 34 14 48
2020 Septiembre 19 14 33
2020 Agosto 28 18 46
2020 Julio 19 8 27
2020 Junio 29 29 58
2020 Mayo 14 21 35
2020 Abril 29 19 48
2020 Marzo 28 13 41
2020 Febrero 6 7 13
2020 Enero 0 2 2
2019 Diciembre 4 2 6
2019 Noviembre 0 2 2
2019 Octubre 0 3 3
2019 Septiembre 4 9 13
2019 Agosto 0 6 6
2019 Julio 0 6 6
2019 Junio 2 17 19
2019 Mayo 0 46 46
2019 Abril 2 21 23
2019 Marzo 2 11 13
2019 Febrero 0 7 7
2019 Enero 2 2 4
2018 Diciembre 1 0 1
2018 Noviembre 1 0 1
2018 Octubre 3 0 3
2018 Septiembre 2 0 2
2018 Mayo 0 4 4
2018 Marzo 0 1 1
2018 Febrero 27 8 35
2018 Enero 40 6 46
2017 Diciembre 36 5 41
2017 Noviembre 21 8 29
2017 Octubre 28 4 32
2017 Septiembre 31 4 35
2017 Agosto 35 8 43
2017 Julio 41 2 43
2017 Junio 36 15 51
2017 Mayo 39 16 55
2017 Abril 31 24 55
2017 Marzo 26 26 52
2017 Febrero 28 7 35
2017 Enero 31 11 42
2016 Diciembre 41 13 54
2016 Noviembre 41 17 58
2016 Octubre 39 24 63
2016 Septiembre 38 11 49
2016 Agosto 34 6 40
2016 Julio 34 3 37
2016 Junio 8 11 19
2016 Mayo 11 13 24
2016 Abril 4 0 4
2016 Marzo 5 0 5
2016 Febrero 8 1 9
2016 Enero 8 2 10
2015 Diciembre 6 1 7
2015 Noviembre 5 4 9
2015 Octubre 13 5 18
2015 Septiembre 1 1 2
2015 Agosto 10 3 13
2015 Julio 38 12 50
2015 Junio 33 2 35
2015 Mayo 101 10 111
2015 Abril 41 11 52
2015 Marzo 40 9 49
2015 Febrero 27 6 33
2015 Enero 34 10 44
2014 Diciembre 41 10 51
2014 Noviembre 29 11 40
2014 Octubre 49 19 68
2014 Septiembre 38 11 49
2014 Agosto 29 15 44
2014 Julio 56 21 77
2014 Junio 70 10 80
2014 Mayo 77 13 90
2014 Abril 57 14 71
2014 Marzo 80 18 98
2014 Febrero 54 16 70
2014 Enero 55 18 73
2013 Diciembre 68 13 81
2013 Noviembre 48 19 67
2013 Octubre 52 19 71
2013 Septiembre 40 20 60
2013 Agosto 6 11 17
2013 Julio 7 21 28
2013 Junio 8 14 22
2013 Mayo 7 16 23
2013 Abril 16 15 31
2013 Marzo 31 8 39
2013 Febrero 130 5 135
2013 Enero 38 6 44
2012 Diciembre 14 3 17
2012 Noviembre 0 1 1
2012 Septiembre 1 0 1
2012 Agosto 2 0 2
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?